SEPTInvestingStart Free

BDRX 424B3: Stock split

Biodexa Pharmaceuticals

Filed with the SEC on · accession 0001214659-26-012864

BDRX filed a 424B3 (prospectus (offering)) with the SEC on Oct 14, 2026. Biodexa Pharmaceuticals announced a change to its ADS ratio from 1 ADS representing 50 ordinary shares to 1 ADS representing 400 ordinary shares, effective on or about October 26, 2026. The stock moved +38.5% by the first close after the filing.

Summary of the filing

Biodexa Pharmaceuticals announced a change to its ADS ratio from 1 ADS representing 50 ordinary shares to 1 ADS representing 400 ordinary shares, effective on or about October 26, 2026. This has the same effect for ADS holders as a one-for-eight reverse ADS split, requiring mandatory surrender of old ADSs for new ones.

For details, click here →How to read a 424B3 →

Key details

IssuerBiodexa Pharmaceuticals PLC
DepositaryJPMorgan Chase Bank, N.A.
Chief executive officerStephen Stamp

How BDRX stock reacted

Close before

$2.80

Oct 13, 2026

First close after

+38.46%

$3.88

5 trading days

+10.08%

$3.08

Since filing

-11.84%

$2.47

✦ Ask GOAX AI about this filing — what it means for BDRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BDRX?

Click here

Frequently asked questions

What did BDRX file with the SEC on Oct 14, 2026?

BDRX filed a 424B3 (Stock split). Biodexa Pharmaceuticals announced a change to its ADS ratio from 1 ADS representing 50 ordinary shares to 1 ADS representing 400 ordinary shares, effective on or about October 26, 2026. This has the same effect for ADS holders as a one-for-eight reverse ADS split, requiring mandatory surrender of old ADSs for new ones.

What does a stock split mean for BDRX stock?

Usually: fewer shares means each remaining share owns more of the company. It matters whether the company actually buys and at what price.

How do I read a 424B3?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did BDRX stock react to this filing?

BDRX closed at $2.80 before the filing and $3.88 on Oct 14, 2026 (+38.46%). Five trading days later: $3.08 (+10.08%).

Other BDRX SEC filings

Get alerts when BDRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
BDRX overviewBDRX analysisBDRX newsLatest SEC filings